Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,038 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Parallel multi-droplet platform for reaction kinetics and optimization.
Eyke NS, Schneider TN, Jin B, Hart T, Monfette S, Hawkins JM, Morse PD, Howard RM, Pfisterer DM, Nandiwale KY, Jensen KF. Eyke NS, et al. Among authors: hart t. Chem Sci. 2023 Aug 4;14(33):8798-8809. doi: 10.1039/d3sc02082g. eCollection 2023 Aug 23. Chem Sci. 2023. PMID: 37621435 Free PMC article.
A robotic platform for flow synthesis of organic compounds informed by AI planning.
Coley CW, Thomas DA 3rd, Lummiss JAM, Jaworski JN, Breen CP, Schultz V, Hart T, Fishman JS, Rogers L, Gao H, Hicklin RW, Plehiers PP, Byington J, Piotti JS, Green WH, Hart AJ, Jamison TF, Jensen KF. Coley CW, et al. Among authors: hart aj, hart t. Science. 2019 Aug 9;365(6453):eaax1566. doi: 10.1126/science.aax1566. Science. 2019. PMID: 31395756
Autonomous, multiproperty-driven molecular discovery: From predictions to measurements and back.
Koscher BA, Canty RB, McDonald MA, Greenman KP, McGill CJ, Bilodeau CL, Jin W, Wu H, Vermeire FH, Jin B, Hart T, Kulesza T, Li SC, Jaakkola TS, Barzilay R, Gómez-Bombarelli R, Green WH, Jensen KF. Koscher BA, et al. Among authors: hart t. Science. 2023 Dec 22;382(6677):eadi1407. doi: 10.1126/science.adi1407. Epub 2023 Dec 22. Science. 2023. PMID: 38127734
Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 diabetes after 26 weeks' treatment: A randomized open label study.
Christofides EA, Puente O, Norwood P, Denham D, Maheshwari H, Lillestol M, Hart T, Nakhle S, Chadha A, Fitz-Patrick D, Sugimoto D, Soufer J, Young D, Warren M, Huffman D, Reed J, Bays H, Arora S, Rizzardi B, Tidman R, Rendell M, Johnson KA. Christofides EA, et al. Among authors: hart t. Diabetes Obes Metab. 2024 Jun;26(6):2412-2421. doi: 10.1111/dom.15560. Epub 2024 Apr 1. Diabetes Obes Metab. 2024. PMID: 38558508 Clinical Trial.
1,038 results